INTEGRATED HEALTHCARE QUALITY MANAGEMENT

Transcription

1 NGD P H N Y G CY N VD D G N C P D N N Y NC C C D D C HHC QUY NGN

2 PH CY N VD NGD is the solution that provides access to the entirety of the VD C modules for all Healthcare nformation ystems and eprescription applications. he extent of available functionalities is based on an innovative P (pplication Programming nterface) architecture that covers 4 main domains: Drug search and identification, lerts, ubstitution and Documentation. P D N Y N G N G D HC QUY NG H N D U VD NGD key functionalities U B U N CH VD NG D N N U DC By means of comprehensive integration expertise, VD supplies its partners with an overarching access to its reference information and Decision upport odules, and helps improve the overall prescription safety and optimize medication management cycles. V 1 ccess to locally available drugs 2 Wide array of Drug-Drug and Drug-Patient alerts (based on VD Core s Decision upport odules) 3 eference Documentation (Drug onographs and structured Drug information) 4 nnovative P technology allowing straightforward integration and deployment 5 ingle interface for several drug databases 6 nteroperability with standard terminologies in healthcare (C, CD ) D C D V Y C G V D D C CHN N C D Y NC C G N F N Y

3 VD C CHNGY VD Drug nformation ystems are underpinned by an international repository of Virtual edicinal Products (VP) linked to a broad semantic network detailing the usage, clinical effects, and potential risks for each drug. he information is highly structured and regularly updated by our team of pharmacists. n each concerned country, VD closely monitors the formularies issued by relative official health authorities and adapts its information to the local needs in order to provide healthcare professionals with a reliable source of information on the drugs that are accessible in their everyday practice. FNC PN PUG BGU CH UD B XC U NNN VU DUG D N VD DUG NFN Y VD C CHNGY VD C CHNGY

4 earch functions P access to the whole graph of drug information facilitates the implementation of a large variety of search functionalities. Criteria that may be used to lookup branded or generic drugs include: Product name ngredient ocal code C Classification herapeutic indication ubstitution functions imilarly, proposing drug alternatives to the healthcare professional may be based on a variety of strategies, such as: imilar product (same ingredient, dosage, form and route of administration) C classification herapeutic indication

5 lerts functions Drug llergy odule Checks the risk of allergic reactions between drugs and patient-known allergens. Cross-sensitivity reactions are included in this detection. Drug interactions odule he VD drugs database provides data on clinically relevant drug to-drug interaction involving pharmacological or pharmacokinetic mechanisms. n interaction is described by: risk level based on the following severity scale: Contraindication Not recommended Caution o be taken into account description of the interaction mechanism. Patient monitoring information, if available, with appropriate actions to be taken in response to the alert. Drug Health odule ncluding Drug Pathologies odule, Drug ge odule, Drug Weight odule, Drug ex odule, Drug Pregnancy odule, Drug actation odule, Drug enal Failure odule, etc. he aim of the drug health module is to help physicians to confidently determine what will be a safe and appropriate medication for a patient in relation to his specific medical condition. Drug Duplicate herapy odule he presence of the same active substance or a parent one in two drugs belonging to the same prescription can be detected in order to prevent any over dosage and adverse toxicity events. Drug Warning odule Provides warning on specific patient monitoring or prevents special risks linked to drug prescription. hese would entail taking into account and monitoring biological parameters throughout the treatment in order to reduce morbidity and harm to patients.

6 Documentation functions and structured data VD NGD provides third-party applications with rapid access to reference clinical information on drugs, curated by a team of healthcare experts (pharmacists, physicians, pharmacologists) and based on national and international reference sources. Product nformation (tructured Data) Brand name Generic name (Virtual Drug name) National code C classification (WH) ctive ingredient(s) ndications oute(s) of administration Pharmaceutical form Contraindications llergies Precautions dverse effects Drug interactions Packaging information Home > Hyzaar 100 mg/25 mg Hyzaar 100 mg/25 mg Generic: hydrochlorothiazide * 25 mg + losartan potassium * 100 mg ; oral use ; tablet ndications Dosage & administration Warnings reatment monitoring nteractions Contraindications Precautions Hyzaar 100 mg/25 mg Pregnancy & lactation pecific risks Food interactions dverse effects Package information Warnings (drug-food interactions, specific risks...) Cautions for usage Performance-enhancing information verview Drug details ctive ingredients trength Form oute hydrochlorothiazide losartan potassium C Class Code C09D01 Name 25 mg 100 mg N ND DUC Drug equivalents (same form, route and active ingredients) FZ film-coated tablet 100 mg+25 mg K PU D film-coated tablet 25 mg mg ZG H film-coated tablet 25 mg mg tablet oral use ee foreign brands matching the C Class >> he therapeutic information mentionned on this page refers to the properties of the Generic, and should not be considered as extensive information related to the branded product dd to prescription checker Use in eproductive health (risk) Vigilance port Pregnancy (months) act X X Details eference documentation Printable monograph for: hydrochlorothiazide * 25 mg + losartan potassium * 100 mg ; oral use ; tablet Generic monograph ncluding: Generic Name Drug classification dministration Dosage and indications Drug interactions eproductive health warnings ethod of action dverse effects Food interactions Drug onitoring Contraindications & Precautions pecial safety measures...

7 Content VD databases and Decision upport odules are elaborated from validated local formularies and internationally recognized official sources (, FD, N,...) by a multinational team of health experts in 8 uropean countries (pharmacists, pharmacologists, physicians, scientists, database architects, medical informatics specialists). Kuwait urkey For the iddle ast, the contents of the VD database complies with the main official drug formularies in the region (HD, FD, DH...) in order to provide healthcare professionals with a reliable solution adapted to the products to which they have access in their everyday practice. yria ran raq ebanon Jordan gypt K Bahrain U Yemen Qatar man VD is present in many uropean countries and in 95% of hospitals in France. s the uropean leader in the field of drug information, VD is also involved in many international health projects such as P (uropean Patients - mart pen ervices) and PP (Patient afety through ntelligent Procedures in medication). echnical details ntegration upport echnology: ocal P Webervices ( upcoming). Platforms: Windows (XP and above), inux. ur support team provides technical assistance and functional advice to our partners all along the integration process. Contacts N egional anagement eam Dr. V. NCK PY وحید نیک پی iddle ast & frica anager مدیر الشرق األوسط وأفریقیا el France: ob. France: el U: ob. U: mail: nick.pay@vidal.fr Head ffice Charles V Product anager el France: mail: charles.metivier@vidal.fr